Edesa Biotech Inc expected to post a loss of 34 cents a share - Earnings Preview

Edesa Biotech

03/12/2021 13:32

* Edesa Biotech Inc  EDSA.OQ   EDSA.O  is expected to show a
fall in quarterly revenue when it reports  results on December 6
(estimated). 
​* Refinitiv's mean analyst estimate for Edesa Biotech Inc is
for a loss of 34 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Edesa Biotech
Inc is $19​, about 69.9% above​ its last closing price
of $5.71. ​​​
This summary was machine generated December 3 at 13:31 GMT.  All
figures in US dollars  unless otherwise stated